Medtronic MiniMed insulin pumps recalled for gravity-related dosing errors
What this means
Medtronic MiniMed insulin pumps (Paradigm, 600, and 700 series) can deliver too much or too little insulin when the pump is positioned higher or lower than your infusion site. This happens because gravity changes the pressure inside the pump. Too much insulin can cause dangerous low blood sugar; too little can cause dangerous high blood sugar and other complications.
- Contact Medtronic immediately to discuss your pump model and treatment options.
- Check your blood sugar more frequently until you receive guidance from your healthcare provider.
- Do not change your insulin dose or routine without talking to your doctor.
- Keep your pump at the same height as your infusion site when possible.
The agency's original wording
All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1740-2026More Medtronic recalls
- FDA-Device2026-07-29Medtronic MiniMed Go App recalled for missed insulin alerts at night
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.